APTOSE BIOSCIENCES INC.
APTOSE BIOSCIENCES INC.
Aktie · CA03835T3091 · APTO · A3EENM (XTSE)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - 4,52 % -38,93 % 787,37 % -93,76 % -99,13 %

Firmenprofil zu APTOSE BIOSCIENCES INC. Aktie

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

Unternehmensdaten

Name APTOSE BIOSCIENCES INC.
Firma Aptose Biosciences Inc.
Symbol APTO
Website https://www.aptose.com
Heimatbörse XTSE Frankfurt
WKN A3EENM
ISIN CA03835T3091
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. William G. Rice Ph.D.
Land Kanada
Währung EUR
Mitarbeiter 0,0 T
Adresse 251 Consumers Road, M2J 4R3 Toronto
IPO Datum 1992-03-16

Aktien-Splits

Datum Split
26.02.2025 1:30

Kennungs-Wechsel

Datum Von Zu
18.11.2008 LRP APTO

Ticker Symbole

Name Symbol
Frankfurt LTI.F
NASDAQ APTO

Weitere Aktien

Investoren die APTOSE BIOSCIENCES INC. die halten, haben auch folgende Aktien im Depot:
AGIF-INDONESIA EQU.A DL
AGIF-INDONESIA EQU.A DL Fonds
SVENSKA HDBK 20/UND. FLR
SVENSKA HDBK 20/UND. FLR Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025